Appropriate preoperative blood typing and cross-matching is an important quality improvement target to minimise costs and rationalise the use of blood bank resources. This can be facilitated using a maximum surgical blood ordering schedule (MSBOS) for specific operations. It is recommended that individual hospitals develop a site-specific MSBOS based on institutional data, but this is challenging in non-tertiary centres without electronic databases. Our aim was to audit our perioperative blood transfusions to develop a site-specific MSBOS. A retrospective audit of blood transfusions in surgical patients in our regional referral hospital was conducted using five years' coded administrative data. Procedures with higher transfusion rates warranting preoperative testing (type and screen with or without subsequent cross-matching) were identified. There were about 15,000 eligible surgical procedures performed in our institution over the audit period. The need for preoperative testing was identified for only a few procedures, namely laparotomy, bowel resection, major amputation, joint arthroplasty, hip/femur fracture and humerus surgery, and procedures for obstetric complications. We observed a reduction in transfusion rates over time for total joint arthroplasty. The use of coding data represents an efficient method by which centres without electronic anaesthesia information management systems can conduct large-scale audits to develop a site-specific MSBOS. This would represent a significant improvement for hospitals that currently base preoperative testing recommendations on expert opinion alone. As many procedures in regional centres have very low transfusion rates, hospitals with a similar case mix to ours could consider selectively auditing higher-risk operations where local data is most likely to alter testing recommendations.
Optimising the ordering of blood group typing and screening and cross-matching is an important target for quality improvement in perioperative care 1 as these tests tend to be ordered excessively compared to the number of patients who require transfusion [2] [3] [4] . The use of guidelines for preoperative testing (type and screen with or without subsequent cross-matching) reduces unnecessary ordering 5 , which has been shown to decrease costs and workload of blood bank staff without adversely impacting on patient care 6, 7 . The first evidence-based approach to blood ordering was proposed by Friedman et al in 1976 8 . Based on an audit of transfusion rates, he developed a 'maximum surgical blood ordering schedule' (MSBOS), consisting of a list of procedures with recommendations for preoperative testing. Transfusion rates for individual procedures have been shown to differ significantly between hospitals, even when adjusted for patient risk factors 9 . It was therefore recommended that individual hospitals develop a site-specific MSBOS 4 , as the need for preoperative testing may vary depending on the procedures performed, surgical and haemostatic techniques, patient population and local transfusion thresholds 10 . Sitespecific MSBOS should also take into account the availability of blood bank resources and staffing levels, which may affect a clinician's ability to obtain blood products urgently without a pre-existing cross-match 11 . MSBOS should be generated based on audits of hospital blood usage, and it has been noted that electronic anaesthesia information management systems can facilitate the collection of large volumes of data 4, 12 . Performing large scale audits in smaller centres can be challenging as data from electronic systems and prospective databases are often not available.
Our project consisted of developing an MSBOS in a regional setting based on an audit of transfusion rates using hospital coding data. As transfusion rates are known to evolve over time, we also performed an analysis of transfusion rates by year for the procedures that most frequently required transfusion.
Materials and methods
This retrospective audit was approved as a quality improvement project (with approval for publication) by the Goulburn Valley Health Human Research Ethics Committee (approval number GVH 21/17).
Setting
Goulburn Valley Health is a 280 bed regional referral centre which services a catchment population of more than 100,000 people. Our blood bank routinely stocks standard blood products, including packed red blood cells of all blood types, around ten units of O negative blood, and one unit of pooled platelets as well as fresh frozen plasma and cryoprecipitate. There is no electronic cross-matching system and only one pathology staff member is present onsite overnight. Additional blood products would generally be brought from Melbourne (around 180 km away) by courier if a specific need were encountered. Intraoperative cell salvage is not available in our facility.
Selection criteria
The audit period was defined as five years commencing 1 May 2012 and ending 30 April 2017. Eligible procedures were elective and emergency operations performed by our major surgical specialties, namely general surgery, orthopaedics, and obstetrics and gynaecology. Our hospital conducts some elective lists performed by visiting surgeons from Melbourne in other specialties (urology, ophthalmology, ear, nose and throat, paediatric general surgery, etc). These surgeons are not locally based and their lists were excluded as they occur relatively infrequently and consist of mostly minor procedures. We also excluded endoscopy and excision of skin lesions as these are low risk and clearly do not require preoperative testing. Emergency endoscopy may be performed in the context of acute bleeding, but for these procedures, and any others in which the patient presents with active bleeding, preoperative testing should be arranged on the basis of clinical parameters rather than MSBOS recommendations.
Data sources
Data regarding patient characteristics, surgical procedures, blood transfusions and the type of products administered were extracted from hospital electronic coding records. Our primary interest was the percentage of patients who received packed red blood cells during their admission. Details of the timing and urgency of transfusion and number of units given were not available. We did not assess which patients had preoperative testing performed or preoperative blood test results in the audit.
Development of MSBOS
Our criteria for warranting preoperative testing were determined a priori based on the probability of transfusion during patient admission. We considered that a 5% risk of transfusion was an appropriate threshold for ordering a blood type and screen, with a minimum 30% risk for ordering crossmatching.
Data analysis
Data extraction and analysis was performed using Stata/ IC 13 (StataCorp LLC, College Station, TX). In order to assess changes over time we performed a statistical comparison of transfusion rates for selected procedures using chi-square test or Fisher's exact test with a significance level taken as P <0.05. Statistical comparisons were exploratory and no power calculation was performed.
Results
In total, 44,960 surgical procedures were performed over the study period, of which 14,989 were eligible for inclusion. The population characteristics are shown in Table 1 . The procedure types, transfusion rates recorded, and our MSBOS recommendations are shown in Tables 2 to 4 (for general surgical, orthopaedic, and obstetric and gynaecology procedures respectively). Separate data for elective and emergency procedures are shown selectively when the rates differed. Analysis of transfusion rates over time is shown in Table 5 for selected high-volume procedures. 
Discussion
Developing institutional guidelines to rationalise preoperative testing in surgical patients can significantly improve staff and blood bank resource utilisation [1] [2] [3] [4] 13 . An audit of transfusion rates for surgical procedures in our regional referral centre demonstrated that the majority of procedures performed were at low risk of transfusion and required no preoperative blood product ordering. The need for any preoperative testing was identified for only a few procedures, namely laparotomy, bowel resection, major amputation, joint arthroplasty, hip/femur fracture and humerus surgery, and procedures for obstetric complications.
The only general surgical procedures that warranted preoperative cross-matching were above and below knee amputations, both of which were rarely performed. We recommend type and screen for bowel resection as well as emergency laparotomy. Regarding gallbladder surgery, while 20% of open cholecystectomy patients received transfusions, conversion from a laparoscopic to an open procedure was rare, which would obviate the need to type and screen solely in case of conversion. While our rate of transfusion in mastectomy was high (5/78 procedures), no patients were transfused intraoperatively and all required transfusion for reasons other than acute blood loss. We therefore felt that preoperative testing can still be omitted for mastectomy patients in the absence of major risk factors. According to our data, the only orthopaedic procedures that required routine blood cross-matching were emergency hip or femoral shaft fractures and revision joint replacement. We recommend type and screen for elective primary total joint arthroplasty, elective hip/femur surgery and surgery to the humerus. In addition, a significant transfusion rate of 8% was found for joint arthroscopies performed emergently in the context of trauma and haemarthrosis. For all other procedures patients were rarely transfused.
The procedures warranting preoperative testing for obstetrics and gynaecology were almost exclusively related to obstetric complications and emergency laparotomies, which were performed for either postsurgical complications or postpartum haemorrhage. Blood ordering in these contexts should clearly be guided by clinical parameters if the patient is actively bleeding. While only 3% of patients with ectopic pregnancy were transfused, we recommend that a type and screen is still indicated in case of sudden catastrophic bleeding. While our current practice for caesarean section is routine type and screen, transfusion rates were low and would support selective preoperative testing for high-risk pregnancies only.
Analysis by year was performed for the few procedures that had a higher rate of transfusion and were undertaken with sufficient frequency to allow meaningful comparison; namely laparotomy, bowel resection, joint arthroplasty and hip/femur fracture surgery. This analysis was intended to be exploratory only, so should be interpreted with caution. The only procedure that showed a statistically significant variation in transfusion rates was elective primary joint arthroplasty, which had a reduction in transfusion rate (from 20% to 8%) over the five years. Nevertheless, the data for the most recent years would still support the recommendation for type and screen prior to joint replacement.
Transfusion rates are known to evolve with time due to better preoperative optimisation of anaemia, changes in surgical and haemostatic techniques and variation in transfusion thresholds, and this should be reflected in regular updates of MSBOS recommendations 1 . As these aspects of blood management are the focus of current initiatives in our institution, we hope that transfusion rates will tend to decline and that over time fewer procedures will require preoperative testing. Having established that only a few procedures in our hospital are associated with significant transfusion rates, updated institutional data could be obtained efficiently in the future through selective audits of the procedures where variation in transfusion rates may change testing recommendations.
Any MSBOS has limitations in its scope and should not be applied universally to all patients. Any patient who is actively bleeding prior to surgery must have blood products ordered on the basis of their clinical parameters. Preoperative anaemia is a ubiquitous risk factor for transfusion across all specialties, and it has been recommended that a lower threshold for preoperative testing should be applied to anaemic patients 14, 15 . In addition, patients with known antibodies or identifiable risk factors for bleeding should have preoperative testing at the discretion of the treating team.
Restricting preoperative testing slightly increases the chance of needing urgent blood without a pre-existing cross-match 15 , but this risk is obviated if O negative blood is available for emergency transfusion. The clinical risk associated with emergency-release blood is minimal, consisting of minor haemolytic reactions in around one in 1,000 units of O negative packed cells 4, 16 . It has also been observed across multiple surgical specialties that the vast majority of transfusions administered do not occur intraoperatively or with particular urgency [17] [18] [19] [20] . The development of a site-specific MSBOS in non-tertiary hospitals can be challenging in the absence of electronic databases and anaesthesia information management systems. We describe one method using coded administrative data, which facilitated the analysis of a large volume of institutional data in order to determine local transfusion rates with reasonable precision. The size of our audit is its major strength, as small volume audits could produce misleading conclusions for procedures with a low event rate for transfusion, which can vary from year to year through chance alone.
There are a number of limitations to our project, including its retrospective design and the inherent potential for coding errors when using administrative data. As the primary aim was to classify procedures as frequently or rarely transfused and this distinction was generally very clear, the presence of coding errors is unlikely to have substantially altered our conclusions. Unfortunately, we were unable to calculate a cross-match to transfusion ratio, as the precise number of packed cells transfused was not available. However, the use of transfusion probability rather than cross-match to transfusion ratio is precedented by multiple authors as an appropriate criteria for MSBOS recommendations 3, 12, 13, 21, 22 . Our analysis of changes in transfusion rates over time was intended to be exploratory only, so should be interpreted with caution. Another limitation was lack of data regarding the timing and context of transfusions because this was not available in hospital coding. Nevertheless, the data obtained still provides substantial information regarding institutional blood usage, which is still preferable to utilising an MSBOS based on consensus opinion without any local audit 10, 13 .
Conclusion
We describe an audit on which to base a site-specific MSBOS in our regional hospital setting using only coded data. Transfusion rates for the majority of operations were low and only a few procedures were identified which met our predefined criteria for preoperative testing. This process represents an efficient method by which centres without electronic anaesthesia information management systems can conduct large scale audits of institutional transfusion rates in order to generate a site-specific MSBOS. As many procedures in regional centres have very low transfusion rates, hospitals with a similar case-mix to ours could consider selectively auditing higher risk operations where local transfusion rates are most likely to alter testing recommendations. 
